Evidence map›Paper›PMID 34946504›Full record

ArticleMolecules (Basel, Switzerland)2021

Imaging-Guided Delivery of a Hydrophilic Drug to Eukaryotic Cells Based on Its Hydrophobic Ion Pairing with Poly(hexamethylene guanidine) in a Maleated Chitosan Carrier.

Sofia A Zakharenkova, Marina I Lebedeva, Alexandra N Lebedeva, Irina A Doroshenko, Ksenya Yu Vlasova, Anastasiya A Bartoshevich, Vladimir M Senyavin, Sergey S Abramchuk, George G Krivtsov, Alexander A Ezhov and 3 more

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.4field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 4 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 2 countries.

Sofia A ZakharenkovaDepartment of Chemistry, Lomonosov Moscow State University, 119991 Moscow, Russia.ORCID 0000-0002-1301-0692
Marina I LebedevaDepartment of Chemistry, Lomonosov Moscow State University, 119991 Moscow, Russia.
Alexandra N LebedevaDepartment of Chemistry, Lomonosov Moscow State University, 119991 Moscow, Russia.
Irina A DoroshenkoDepartment of Chemistry, Lomonosov Moscow State University, 119991 Moscow, Russia.
Ksenya Yu VlasovaDepartment of Chemistry, Lomonosov Moscow State University, 119991 Moscow, Russia.ORCID 0000-0003-3774-1323
Anastasiya A BartoshevichDepartment of Chemistry, Lomonosov Moscow State University, 119991 Moscow, Russia.
Vladimir M SenyavinDepartment of Chemistry, Lomonosov Moscow State University, 119991 Moscow, Russia.
Sergey S AbramchukLaboratory of Physical Chemistry of Polymers, Nesmeyanov Institute of Organoelement Compounds (INEOS RAS), 119991 Moscow, Russia.
George G KrivtsovMechnikov Research Institute for Vaccines and Sera, 105064 Moscow, Russia.
Alexander A EzhovFaculty of Physics, Lomonosov Moscow State University, 119991 Moscow, Russia.ORCID 0000-0001-6221-3093
Tatyana A PodruginaDepartment of Chemistry, Lomonosov Moscow State University, 119991 Moscow, Russia.
Natalia L KlyachkoDepartment of Chemistry, Lomonosov Moscow State University, 119991 Moscow, Russia.ORCID 0000-0002-9357-8236
Mikhail K BeklemishevDepartment of Chemistry, Lomonosov Moscow State University, 119991 Moscow, Russia.ORCID 0000-0002-3020-8537
Lomonosov Moscow State University · RUA. N. Nesmeyanov Institute of Organoelement Compounds · RUResearch Institute of Vaccines and Sera. Mechnikov of the Russian Academy of Medical Sciences · RUTambov State University · RU

Funding

Russian Foundation for Basic Research 20-03-00334a
6 · The paper itself

Abstract

Imaging-guided delivery is developed for hydrophobic drugs, and to a much lesser extent, hydrophilic ones. In this work we have designed a novel strategy for real-time monitoring of hydrophilic drug delivery. Traditionally, the drug and the dye are covalently attached to a nanocarrier or are electrostatically adsorbed. Recently, we found an efficient way to bind the drug by ion-paring with an appropriate counter-ion to form the aggregate that embeds a hydrophobic dye with a considerable fluorescence enhancement. We synthesized a series of carbocyanine dyes of hydrophobicity sufficient for solubilization in hydrophobic ion pairs, which restores their emission in the near-infrared (NIR) region upon the formation of the ternary aggregates. To avoid using toxic surfactants, we applied an amphiphilic polymer-oligomer poly(hexamethylene guanidine) (PHMG) as a counter-ion. Сeftriaxone was used as a model hydrophilic drug ensuring the highest fluorescent signal. The so-formed drug-counter-ion-dye aggregates were encapsulated into a cross-linked maleated chitosan carrier. Confocal laser scanning microscopy (CLSM) studies have demonstrated internalization of the encapsulated model drug by breast adenocarcinoma cells at 40 min after treatment. These results suggest the potential application of hydrophobic ion pairs containing an NIR dye in imaging-guided delivery of hydrophilic compounds.

Indexed as

Drug Delivery SystemsCarbocyaninesCeftriaxoneChitosanDrug CarriersEukaryotic CellsGuanidinesHumansHydrophobic and Hydrophilic InteractionsIonsMolecular StructureCarbocyaninesCeftriaxoneChitosanDrug CarriersGuanidinesIonspolyhexamethyleneguanidinecarbocyanine dyeceftriaxonecross-linked maleated chitosanhydrophobic ion pairingimaging-guided drug deliverypoly(hexamethylene guanidine)

Identifiers

PMID34946504
PMCPMC8703758
OpenAlexW4200576835

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.